Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adiposity | 4 | 2014 | 83 | 1.340 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2025 | 38 | 1.290 |
Why?
|
| Erythrocytes | 3 | 2018 | 149 | 1.140 |
Why?
|
| Diet | 5 | 2020 | 524 | 1.080 |
Why?
|
| Obesity | 13 | 2014 | 1230 | 0.930 |
Why?
|
| Dietary Sucrose | 2 | 2016 | 24 | 0.930 |
Why?
|
| Child Nutritional Physiological Phenomena | 2 | 2014 | 26 | 0.880 |
Why?
|
| Insulin | 4 | 2016 | 686 | 0.800 |
Why?
|
| Overweight | 3 | 2014 | 250 | 0.750 |
Why?
|
| Cognition | 4 | 2022 | 484 | 0.730 |
Why?
|
| Weight Loss | 4 | 2013 | 272 | 0.710 |
Why?
|
| Body Mass Index | 13 | 2016 | 863 | 0.640 |
Why?
|
| Brachial Artery | 6 | 2013 | 29 | 0.640 |
Why?
|
| Intra-Abdominal Fat | 4 | 2014 | 34 | 0.610 |
Why?
|
| Cardiovascular Diseases | 6 | 2025 | 834 | 0.610 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2018 | 6 | 0.600 |
Why?
|
| Longitudinal Studies | 9 | 2022 | 1254 | 0.590 |
Why?
|
| Insulin Resistance | 5 | 2025 | 410 | 0.580 |
Why?
|
| Puerto Rico | 7 | 2025 | 134 | 0.560 |
Why?
|
| Cognition Disorders | 1 | 2018 | 217 | 0.530 |
Why?
|
| Biomarkers | 5 | 2020 | 1397 | 0.500 |
Why?
|
| Boston | 6 | 2020 | 252 | 0.480 |
Why?
|
| Lipogenesis | 1 | 2016 | 68 | 0.470 |
Why?
|
| Endothelium, Vascular | 4 | 2011 | 175 | 0.450 |
Why?
|
| Fatty Acids | 1 | 2016 | 200 | 0.450 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 9 | 0.450 |
Why?
|
| Dairy Products | 1 | 2014 | 15 | 0.440 |
Why?
|
| Oxidative Stress | 1 | 2016 | 297 | 0.430 |
Why?
|
| Beverages | 1 | 2014 | 67 | 0.430 |
Why?
|
| Vasodilation | 3 | 2010 | 36 | 0.410 |
Why?
|
| Child Development | 1 | 2014 | 85 | 0.400 |
Why?
|
| Pediatric Obesity | 1 | 2014 | 109 | 0.390 |
Why?
|
| Diet, Mediterranean | 4 | 2020 | 17 | 0.370 |
Why?
|
| Prospective Studies | 6 | 2018 | 3285 | 0.360 |
Why?
|
| Male | 26 | 2025 | 29821 | 0.340 |
Why?
|
| Female | 27 | 2025 | 32791 | 0.330 |
Why?
|
| Middle Aged | 21 | 2025 | 17553 | 0.330 |
Why?
|
| Metabolic Syndrome | 3 | 2022 | 142 | 0.320 |
Why?
|
| Cross-Sectional Studies | 9 | 2025 | 2571 | 0.320 |
Why?
|
| Absorptiometry, Photon | 3 | 2014 | 76 | 0.320 |
Why?
|
| Depression | 1 | 2016 | 891 | 0.300 |
Why?
|
| Blood Glucose | 5 | 2019 | 483 | 0.300 |
Why?
|
| Waist Circumference | 3 | 2025 | 45 | 0.280 |
Why?
|
| Risk Factors | 9 | 2025 | 5343 | 0.260 |
Why?
|
| Humans | 30 | 2025 | 63297 | 0.250 |
Why?
|
| Triglycerides | 3 | 2016 | 244 | 0.220 |
Why?
|
| England | 2 | 2014 | 29 | 0.220 |
Why?
|
| Adipose Tissue | 3 | 2014 | 295 | 0.210 |
Why?
|
| Linear Models | 2 | 2016 | 409 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 695 | 0.210 |
Why?
|
| Subcutaneous Fat | 3 | 2014 | 47 | 0.210 |
Why?
|
| Cholesterol, LDL | 2 | 2016 | 103 | 0.200 |
Why?
|
| Cohort Studies | 5 | 2020 | 2570 | 0.200 |
Why?
|
| Phosphorus | 1 | 2022 | 16 | 0.200 |
Why?
|
| Kidney Diseases | 1 | 2022 | 176 | 0.170 |
Why?
|
| Ceramides | 1 | 2020 | 25 | 0.170 |
Why?
|
| White Matter | 1 | 2022 | 123 | 0.170 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2020 | 48 | 0.160 |
Why?
|
| Child | 3 | 2014 | 4522 | 0.160 |
Why?
|
| Cause of Death | 1 | 2020 | 221 | 0.160 |
Why?
|
| C-Reactive Protein | 4 | 2022 | 166 | 0.160 |
Why?
|
| Nutritional Status | 2 | 2019 | 98 | 0.150 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2458 | 0.150 |
Why?
|
| Food Supply | 1 | 2019 | 53 | 0.150 |
Why?
|
| Dietary Fats | 2 | 2019 | 175 | 0.150 |
Why?
|
| Adolescent | 3 | 2014 | 6238 | 0.150 |
Why?
|
| Protective Factors | 1 | 2018 | 33 | 0.150 |
Why?
|
| Eating | 1 | 2019 | 138 | 0.150 |
Why?
|
| Executive Function | 1 | 2018 | 65 | 0.140 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 2674 | 0.140 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 777 | 0.140 |
Why?
|
| Self Report | 2 | 2022 | 374 | 0.130 |
Why?
|
| Hypertension | 1 | 2022 | 584 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 58 | 0.130 |
Why?
|
| Deoxyguanosine | 1 | 2016 | 17 | 0.130 |
Why?
|
| Adult | 14 | 2019 | 16781 | 0.120 |
Why?
|
| Feeding Methods | 1 | 2016 | 9 | 0.120 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 73 | 0.120 |
Why?
|
| Blood Flow Velocity | 2 | 2013 | 72 | 0.120 |
Why?
|
| Aged | 9 | 2025 | 14394 | 0.120 |
Why?
|
| Blood Pressure | 3 | 2013 | 509 | 0.120 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 332 | 0.120 |
Why?
|
| Cholesterol | 2 | 2013 | 260 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2016 | 373 | 0.110 |
Why?
|
| Ventricular Function, Left | 2 | 2014 | 270 | 0.110 |
Why?
|
| Diet Records | 1 | 2014 | 34 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 538 | 0.110 |
Why?
|
| Incidence | 1 | 2018 | 1375 | 0.110 |
Why?
|
| Adolescent Development | 1 | 2014 | 16 | 0.110 |
Why?
|
| Diet, Fat-Restricted | 1 | 2014 | 33 | 0.110 |
Why?
|
| Pericardium | 1 | 2014 | 35 | 0.110 |
Why?
|
| DNA Damage | 1 | 2016 | 280 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 182 | 0.110 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 2013 | 3 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 77 | 0.110 |
Why?
|
| Hyperemia | 1 | 2013 | 13 | 0.110 |
Why?
|
| Microcirculation | 1 | 2013 | 52 | 0.100 |
Why?
|
| Risk | 1 | 2014 | 377 | 0.100 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 112 | 0.100 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 935 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 174 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 165 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 212 | 0.100 |
Why?
|
| Inflammation | 3 | 2022 | 1146 | 0.100 |
Why?
|
| Logistic Models | 1 | 2016 | 1275 | 0.100 |
Why?
|
| Omentum | 1 | 2012 | 13 | 0.090 |
Why?
|
| Arterioles | 1 | 2011 | 7 | 0.090 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2011 | 12 | 0.090 |
Why?
|
| Homeostasis | 1 | 2013 | 370 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2010 | 85 | 0.080 |
Why?
|
| Prevalence | 1 | 2014 | 1377 | 0.080 |
Why?
|
| Phenotype | 2 | 2011 | 1200 | 0.080 |
Why?
|
| Choristoma | 1 | 2009 | 22 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2009 | 62 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 574 | 0.080 |
Why?
|
| Exercise | 1 | 2016 | 939 | 0.070 |
Why?
|
| Abdominal Fat | 1 | 2008 | 6 | 0.070 |
Why?
|
| Panniculitis | 1 | 2008 | 4 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2010 | 608 | 0.070 |
Why?
|
| Diet Surveys | 2 | 2019 | 44 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 1543 | 0.070 |
Why?
|
| Peripheral Arterial Disease | 1 | 2010 | 172 | 0.070 |
Why?
|
| Neuropsychological Tests | 2 | 2020 | 391 | 0.070 |
Why?
|
| Heart | 1 | 2009 | 282 | 0.070 |
Why?
|
| Energy Intake | 2 | 2019 | 171 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 2164 | 0.060 |
Why?
|
| Macrophages | 2 | 2011 | 1038 | 0.060 |
Why?
|
| Brazil | 1 | 2025 | 100 | 0.060 |
Why?
|
| Adipocytes | 1 | 2007 | 268 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 113 | 0.050 |
Why?
|
| Cattle | 1 | 2022 | 308 | 0.050 |
Why?
|
| Biological Availability | 1 | 2022 | 200 | 0.050 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2020 | 9 | 0.040 |
Why?
|
| Kidney | 1 | 2022 | 447 | 0.040 |
Why?
|
| Bone Density | 1 | 2020 | 134 | 0.040 |
Why?
|
| Food Analysis | 1 | 2019 | 31 | 0.040 |
Why?
|
| Postmenopause | 1 | 2020 | 237 | 0.040 |
Why?
|
| Memory | 1 | 2019 | 120 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 893 | 0.040 |
Why?
|
| Life Style | 1 | 2019 | 311 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2010 | 483 | 0.030 |
Why?
|
| Nutritional Requirements | 1 | 2016 | 20 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2016 | 21 | 0.030 |
Why?
|
| Malnutrition | 1 | 2016 | 41 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2016 | 123 | 0.030 |
Why?
|
| Vietnam | 1 | 2016 | 173 | 0.030 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2016 | 90 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2017 | 259 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 721 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 22 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 30 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 2014 | 28 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 197 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2014 | 108 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 176 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2014 | 248 | 0.020 |
Why?
|
| Biopsy | 1 | 2014 | 444 | 0.020 |
Why?
|
| Antigens, CD19 | 1 | 2012 | 22 | 0.020 |
Why?
|
| Papaverine | 1 | 2011 | 7 | 0.020 |
Why?
|
| Nitroprusside | 1 | 2011 | 14 | 0.020 |
Why?
|
| Vasomotor System | 1 | 2011 | 22 | 0.020 |
Why?
|
| Young Adult | 2 | 2014 | 4682 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 68 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2011 | 60 | 0.020 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2009 | 11 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 112 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1083 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 20 | 0.020 |
Why?
|
| Animals | 2 | 2022 | 20631 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1359 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2008 | 11 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2008 | 39 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 220 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 548 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 108 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2008 | 347 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 517 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2009 | 1121 | 0.020 |
Why?
|
| Body Weight | 1 | 2008 | 377 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 614 | 0.010 |
Why?
|
| Sex Factors | 1 | 2008 | 979 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 3033 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 1539 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 6630 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 10827 | 0.010 |
Why?
|